A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

© 2019 The Author(s). Background: To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand. Methods: A prospective, multi-centre, observational study was conducted among eight hospita...

Saved in:

書目詳細資料
Main Authors:	Suthasinee Kumluang, Lily Ingsrisawang, Sermsiri Sangroongruangsri, Usa Chaikledkaew, Tanapat Ratanapakorn, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Somanus Thoongsuwan, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Pattara Leelahavarong, Yot Teerawattananon
格式:	雜誌
出版:	2019
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063749750&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65770
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
由: Suthasinee Kumluang, et al.
出版: (2020)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
由: Sermsiri Sangroongruangsri, et al.
出版: (2018)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
由: Sermsiri Sangroongruangsri, et al.
出版: (2019)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)
由: Sermsiri Sangroongruangsri, et al.
出版: (2019)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)
由: Sermsiri Sangroongruangsri, et al.
出版: (2020)

Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
由: Sermsiri Sangroongruangsri, et al.
出版: (2019)

Intravitreal bevacizumab injection in advanced retinopathy of prematurity.
由: Janejit Choovuthayakorn, et al.
出版: (2018)

Cost-utility analysis of drug treatments in patients with polypoidal choroidal vasculopathy in Thailand
由: Sermsiri Sangroongruangsri, et al.
出版: (2022)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
由: Thunyarat Anothaisintawee, et al.
出版: (2018)

Intravitreal bevacizumab injection in advanced retinopathy of prematurity.
由: Choovuthayakorn J., et al.
出版: (2014)

Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: Results of a 1-year preliminary study
由: Paisan Ruamviboonsuk, et al.
出版: (2018)

Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)
由: Somanus Thoongsuwan, et al.
出版: (2022)

Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: A pilot study
由: Kaevalin Lekhanont, et al.
出版: (2018)

Stability of bevacizumab divided in multiple doses for intravitreal injection
由: Nopasak Phasukkijwatana, et al.
出版: (2018)

Intravitreal Ranibizumab Treatment for Non-Proliferative Idiopathic Macular Telangiectasia Article Sidebar
由: Wichai Prasartritha, et al.
出版: (2022)

Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma
由: Naris Kitnarong, et al.
出版: (2018)

Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration
由: Wickremasinghe, S.S., et al.
出版: (2014)

Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD
由: Wickremasinghe, S.S., et al.
出版: (2014)

Economic Evaluations of Artificial Intelligence in Ophthalmology
由: Paisan Ruamviboonsuk, et al.
出版: (2022)

Epidemiology of age-related macular degeneration among the elderly population in Thailand
由: Rossukon Khotcharrat, et al.
出版: (2018)

Epidemiology of age-related macular degeneration among the elderly population in Thailand
由: Rossukon Khotcharrat, et al.
出版: (2018)

Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period
由: Wickremasinghe, S.S., et al.
出版: (2014)

Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity
由: L. O. Atchaneeyasakul, et al.
出版: (2018)

Cost-effectiveness analysis of vision screening program in schools under Bangkok metropolitan authority
由: Prut Hanutsaha
出版: (2003)

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
由: D. A. Reardon, et al.
出版: (2018)

Bevacizumab for retinopathy of prematurit
由: Lim, L.S., et al.
出版: (2014)

Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma
由: Arman Mashayekhi, et al.
出版: (2018)

Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion
由: Tan, M.H., et al.
出版: (2014)

Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
由: Joseph, Rini Rachel, et al.
出版: (2018)

Acute Intraocular Inflammation after Intravitreous Injections of Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
由: Wickremasinghe, S.S., et al.
出版: (2014)

Bioactivty and controlled release studies of ranibizumab from polymeric carriers
由: Chua, Hui Yee
出版: (2018)

Formulation and in-vitro release studies of Ranibizumab (Lucentis) loaded liposomes
由: Ang, Jin Yan
出版: (2013)

Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
由: Pitipol Choopong, et al.
出版: (2017)

Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments
由: Voraporn Chaikitmongkol, et al.
出版: (2018)

Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments
由: Voraporn Chaikitmongkol, et al.
出版: (2018)

Sheathotomy without separation of venule overlying arteriole at occlusion site in uncommon branch retinal vein occlusion
由: Nuttawut Rodanant, et al.
出版: (2018)

Cost analysis for reimbursement-rate setting of hospital pharmaceutical services in Thailand
由: Arthorn Riewpaiboon, et al.
出版: (2018)

Current evidence of temozolomide and bevacizumab in treatment of gliomas
由: Danop Nanegrungsunk, et al.
出版: (2018)

Current evidence of temozolomide and bevacizumab in treatment of gliomas
由: Danop Nanegrungsunk, et al.
出版: (2018)

The effect of subconjunctival bevacizumab on angiogenesis in rabbit model
由: Nurwasis, Nurwasis, et al.
出版: (2019)